# Eli Lilly
Latest news and articles about Eli Lilly
Total: 3 articles found
Eli Lilly Bets $7 Billion on the ‘Holy Grail’ of Cancer Therapy to Diversify Beyond Weight Loss
Eli Lilly is acquiring Kelonia Therapeutics for up to $7 billion to gain access to its revolutionary in-vivo CAR-T technology. This strategic move aims to diversify Lilly's portfolio beyond its successful weight-loss business and establish a leading position in the high-growth oncology market.
NVIDIA’s Strategic Gambit and Biotech M&A Surge Fuel Wall Street Rally
US markets opened strongly on March 31, 2026, driven by NVIDIA’s $2 billion investment in Marvell and a massive wave of biotech acquisitions by Biogen and Eli Lilly. This tech and healthcare-led rally stands in stark contrast to European markets, which faced a double-digit decline over the course of the month.
The Algorithmic Apothecary: Insilico Medicine Nets High-Stakes AI Drug Pact with Eli Lilly
Insilico Medicine has entered a strategic collaboration with Eli Lilly to utilize generative AI for drug discovery, marking a significant milestone in the integration of AI into Big Pharma's R&D pipelines. The partnership validates Insilico's Pharma.AI platform and signals a broader industry shift toward algorithmic molecular design.